Overview

Global Scar Treatment Market is estimated to value over USD 28.5 billion by 2026 end and register a CAGR of over 9.7% during the forecast period 2019 to 2026.

The scar treatment market size is expanding rapidly because a great deal of emphasis is placed on the value of aesthetics and removal of acne scars have become the preoccupation of many people. Furthermore, there has been an alarming rate of road accidents which subsequently culminates in several bodily marks and lacerations. Such occurrences may call for extensive surgical aid. As a result, patients who have encountered such surgical procedures are given topical products which are generally used to reduce scars.

Cosmetic procedures involving the use of laser instruments are taken up for the treatment of severe wounds penetrated deep into the human body. In an effort to remove such marks, plastic surgery procedures and laser therapies are considered as viable options. Furthermore, technologically innovative treatments such scar removal products provide aid in the reduction of pain as well as offer a healing process that is devoid of hassles or complications. These are factors which are likely to garner considerable scar treatment market share. One such example of these products includes UltraPulse produced by the company Lumenis. This product uses a laser known as CO2 which facilitates the treatment of acne related scars and thereby, reduces the likelihood of pain in the treatment process. The scar treatment market growth has witnessed a steady rise due to the demand for such topical products which includes gels and creams for the treatment of surgical marks, for acne related issues and even burn marks.

Market study shows that the topical products market is estimated to gain significant traction and is likely to maintain their market dominance in the years to come. This is due, in part, because of silicone sheets, topical gels becoming easily accessible as over-the-counter products which has maximized their utilization as a treatment for scars.

Going by the segmentation of treatment types, the market has been fragmented into injectable, topical, surface and laser with topical predicted to account for the dominant scar treatment market share in the global market for scar treatment in the forecast timeline and the growth is expected to experience greater strides in the future due to the rise in adoption of gels and creams for the healing of scars namely acne, burns and surgical marks, along with affordability, easy accessibility and user-friendliness. 

With scar type, scar treatment is categorized into post-surgical scars, acne scars, stretch marks, hypertrophic scar, contracture scar and keloid scar. The categories of hypertrophic and keloid scars are anticipated to augment segmental growth due to the volume of burn cases. However, it is the post-surgical scar category which is likely to witness a surge in scar treatment market growth.

It has been anticipated that the laser products will experience an augmentation in growth during the forecast time span. A few of the major players who are dominating the market for scar removal includes Sonoma Pharmaceuticals, Inc.; CCA Industries, Inc., Smith & Nephew plc, Mölnlycke Health Care, Scarheal, Inc., Merz, Inc., Cynosure Inc. and Lumenis.

Scar Treatment Market Segmentation:

By Treatment Type

• Topical Products
• Laser Treatment
• Injectables
• Others

By Scar Type

•   Atrophic & Acne Scars
•   Hypertrophic Scars and Keloids
•   Contracture Scars
•   Others (Stretch Marks)

By Distribution Channel

•  Hospital Pharmacies
•  Retail Pharmacies
•  Online Pharmacies

By Region

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East & Africa

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the scar treatment market by treatment type, by scar type, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

        1.2.1 Markets Covered

        1.2.2 Years Considered for the Study

1.3 Currency 

1.4 Limitations 

1.5 Stakeholders 

2 Research Methodology 

2.1 Research Approach 

2.2 Research Data 

        2.2.1 Secondary Sources

                 2.2.1.1 Key Data From Secondary Sources

        2.2.2 Primary Sources

                 2.2.2.1 Key Data From Primary Sources

                 2.2.2.2 Breakdown of Primary Interviews

2.3 Market Size Estimation 

2.4 Market Breakdown and Data Triangulation 

2.5 Research Assumptions 

3 Executive Summary 

4 Market Overview

      4.1. Introduction

      4.2. Market Definition

5. Market Dynamics

      5.1. Drivers and Restraints Snapshot Analysis

      5.2. Drivers

      5.3. Restraints

      5.4. Opportunity

6. The Global Scar Treatment Market Analysis and Forecast, 2019 to 2026

      6.1. Market Revenue Projections

      6.2. Global Scar Treatment Market Outlook

      6.3. Pipeline Analysis

      6.4. Key product/brand Analysis

7. Global Scar Treatment Market Analysis, by Treatment Type

      7.1. Introduction

      7.2. Global Scar Treatment Market Value Share Analysis, by Treatment Type

      7.3. Global Scar Treatment Market Forecast, by Treatment Type

             7.3.1. Topical Products

             7.3.2. Laser Treatment

             7.3.3. Injectables

            7.3.4. Others

      7.4. Global Scar Treatment Market Analysis, by Treatment Type

     8. Global Scar Treatment Market Analysis, by Scar Type

     8.1. Key Findings

      8.2. Introduction

      8.3. Global Scar Treatment Market Value Share Analysis, by Scar Type, 2019 to 2026

      8.4. Global Scar Treatment Market Forecast, by Scar Type

             8.4.1. Atrophic & Acne Scars

             8.4.2. Hypertrophic Scars and Keloids

             8.4.3. Contracture Scars

             8.4.4. Others (Stretch Marks)

    9. Global Scar Treatment Market Analysis, by Distribution Channel

      9.1. Key Findings

      9.2. Introduction

      9.3. Global Scar Treatment Market Value Share Analysis, by Distribution   Channel

      9.4. Global Scar Treatment Market Forecast, by Distribution Channel

             9.4.1. Hospital Pharmacies

             9.4.2. Retail Pharmacies

             9.4.3. Online Pharmacies

10. Global Scar Treatment Market Analysis, by Region

      10.1. Global Scar Treatment Market Scenario, by Country/Sub-region

      10.2. Global Scar Treatment Market Value Share Analysis, by Region

      10.3. Global Scar Treatment Market Forecast, by Region

            10.3.1. North America

             10.3.2. Europe

             10.3.3. Asia Pacific

             10.3.4. Latin America

             10.3.5. Middle East & Africa

11 Competition Matrix

     11.1. Scar Treatment Market Share Analysis, by Company, 2018

     11.2. Company Profiles

            11.2.1. Valeant Pharmaceuticals International, Inc.

                     11.2.1.1. Company Profiles

                     11.2.1.2. Business Overview

                     11.2.1.3. Strategic Overview

                     11.2.1.4. SWOT Analysis

            11.2.2. Sonoma Pharmaceuticals

                     11.2.2.1. Company Profiles

                     11.2.2.2. Business Overview

                     11.2.2.3. Strategic Overview

                     11.2.2.4. SWOT Analysis

            11.2.3. Pacific World Corporation

                     11.2.3.1. Company Profiles

                     11.2.3.2. Business Overview

                     11.2.3.3. Strategic Overview

                     11.2.3.4. SWOT Analysis

            11.2.4. Merz Pharma

                     11.2.4.1. Company Profiles

                     11.2.4.2. Business Overview

                     11.2.4.3. Strategic Overview

                     11.2.4.4. SWOT Analysis

            11.2.5. Sientra, Inc.

                     11.2.5.1. Company Profiles

                     11.2.5.2. Business Overview

                     11.2.5.3. Strategic Overview

                     11.2.5.4. SWOT Analysis

            11.2.6. Velius, LLC.

                     11.2.6.1. Company Profiles

                     11.2.6.2. Business Overview

                     11.2.6.3. Strategic Overview

                     11.2.6.4. SWOT Analysis

            11.2.7. CCA Industries, Inc.

                     11.2.7.1. Company Profiles

                     11.2.7.2. Business Overview

                     11.2.7.3. Strategic Overview

                     11.2.7.4. SWOT Analysis

            11.2.8. Molnlycke Health Care AB (Investor AB)

                     11.2.8.1. Company Profiles

                     11.2.8.2. Business Overview

                     11.2.8.3. Strategic Overview

                     11.2.8.4. SWOT Analysis

            11.2.9. Fosun Pharmaceutical Co., Ltd (Alma Lasers)

                     11.2.9.1. Company Profiles

                     11.2.9.2. Business Overview

                     11.2.9.3. Strategic Overview

                     11.2.9.4. SWOT Analysis

            11.2.10. Cutera, Inc.

                     11.2.10.1. Company Profiles

                     11.2.10.2. Business Overview

                     11.2.10.3. Strategic Overview

                     11.2.10.4. SWOT Analysis

            11.2.11. XIO Group (Lumenis)

                     11.2.11.1. Company Profiles

                     11.2.11.2. Business Overview

                     11.2.11.3. Strategic Overview

                     11.2.11.4. SWOT Analysis

            11.2.12. Smith & Nephew plc

                     11.2.12.1. Company Profiles

                     11.2.12.2. Business Overview

                     11.2.12.3. Strategic Overview

                     11.2.12.4. SWOT Analysis

            11.2.13. Alliance Pharma

                     11.2.13.1. Company Profiles

                     11.2.13.2. Business Overview

                     11.2.13.3. Strategic Overview

                     11.2.13.4. SWOT Analysis

12 Research Finding and Conclusion

13 Research Methodology

14 Research Data Source

Tables

Figures